VeriMomr-clostridium histolyticum collagenase g est-il sûr pendant la grossesse ?
No harmonised reproductive hazard (H360/H361) for C. histolyticum collagenase was found. Clinical and regulatory sources (drug monographs / FDA/EMA product information and PubMed clinical literature) describe local enzymatic effects and injection-site risks but do not report developmental or teratogenic effects; no CIR or SCCS safety assessment for cosmetic topical use was identified. Sources: clinical drug monographs and PubMed summaries show use as an injected medical product without reproductive classification. ([drugs.com](https://www.drugs.com/monograph/collagenase-clostridium-histolyticum.html?utm_source=openai))
Related ingredients
Frequently asked questions
- r-clostridium histolyticum collagenase g est-il sûr pendant la grossesse ?
- No harmonised reproductive hazard (H360/H361) for C. histolyticum collagenase was found. Clinical and regulatory sources (drug monographs / FDA/EMA product information and PubMed clinical literature) describe local enzymatic effects and injection-site risks but do not report developmental or teratogenic effects; no CIR or SCCS safety assessment for cosmetic topical use was identified. Sources: clinical drug monographs and PubMed summaries show use as an injected medical product without reproductive classification. ([drugs.com](https://www.drugs.com/monograph/collagenase-clostridium-histolyticum.html?utm_source=openai))
- r-clostridium histolyticum collagenase g est-il sûr pendant l'allaitement ?
- No evidence in peer‑reviewed literature or regulatory monographs of effects on lactation or transfer in breastmilk. As a high‑molecular‑weight protein/enzyme used in injectable formulations, systemic exposure in cosmetic topical use is expected to be negligible; no studies showing breastmilk transfer or lactation toxicity were located. ([drugs.com](https://www.drugs.com/monograph/collagenase-clostridium-histolyticum.html?utm_source=openai))
- r-clostridium histolyticum collagenase g est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no infant‑specific reproductive or developmental toxicity evidence was found (h=0, m=0). Exposure: dermal absorption of large enzymes is expected to be negligible in adults (e=0) but, per your calibration rule, infant/0–3 y skin barrier immaturity increases exposure rating by +1 to e=1 if the ingredient has measurable absorption potential. Enzyme products and SDSs emphasise respiratory sensitisation risk (inhalation) rather than dermal systemic toxicity. No baby‑specific studies located. ([sigmaaldrich.com](https://www.sigmaaldrich.com/catalog/product/roche/collhro?utm_source=openai))
- Comment VeriMom évalue-t-il r-clostridium histolyticum collagenase g ?
- VeriMom évalue r-clostridium histolyticum collagenase g à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à r-clostridium histolyticum collagenase g pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à r-clostridium histolyticum collagenase g basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.